Frequency and causes of refractoriness in multiply transfused patients

Annals of Hematology

Volumn 74, Issue 4, 1997, Pages 185-189

  Legler, T J ^a   Fischer, I ^a   Dittmann, J ^a   Simson, G ^a   Lynen, R ^a   Humpe, A ^a   Riggert, J ^a   Schleyer, E ^a   Kern, W ^a   Hiddemann, W ^a   Kohler M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cross match; HLA antibodies; HPA antibodies; Leukodepleted blood components; Refractoriness

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; THROMBOCYTE ANTIBODY;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; SEPSIS; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE;

ANTIGENS, HUMAN PLATELET; FEMALE; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; IMMUNOGLOBULIN G; ISOANTIBODIES; LEUKAPHERESIS; MALE; PLATELET TRANSFUSION;

EID: 0031006379     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050280     Document Type: Article

References (23)

1. Beutler E (1993) Platelet transfusions: the 20000/μl trigger. Blood 81:1411-1413
2. Bishop JF, Matthews JP, Yuen K, McGrath K, Wolf MM, Szer J (1992) The definition of refractoriness to platelet transfusions. Transfus Med 2:35-41
3. Brand A, Claas FHJ, Voogt PJ, Wasser MNJM, Eerniss JG (1988) Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sang 54:160-166
4. Dutcher JP, Schiffer CA, Aisner J, Wiernik PH (1981) Long-term follow-up of patients with leukaemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunised. Blood 58:1007-1011
5. Friedberg RC, Donnelly SF, Boyd JC, Gray LS, Mintz PD (1993) Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood 81:3428-3434
6. Godeau B, Fromont P, Seror T, Duedari N, Bierling P (1992) Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients. Br J Haematol 81:395-400
7. Heddle NM, Blajchman MA (1995) The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions. Blood 85:603-606
8. Howard JE, Perkins HA (1978) The natural history of alloimmunisation to platelets. Transfusion 18:496-503
9. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C (1987) Monoclonal antibody-specific immobilisation of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 70:1722-1726
10. Klein HG (1992) Wolf in wolf's clothing: is it time to raise the bounty on the passenger leukocyte? Blood 80:1865-1868
11. Köhler M, Dittmann J, Legler TJ, Lynen R, Humpe, Riggert J, Neumeyer H, Pies A, Panzer S, Mayr WR (1996) Flow cytometric detection of platelet-reactive antibodies and application in platelet crossmatching. Transfusion 36:250-255
12. Legler TJ Köhler M, Mayr WR, Panzer S, Ohto H, Fischer GF (1996) Genotyping of the human platelet antigen systems 1 through 5 by multiplex polymerase chain reaction and ligation-based typing. Transfusion 36:426-431
13. McFarland JG, Anderson AJ, Slichter SJ (1989) Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 73:380-386
14. Mc Grath K, Wolf M, Bishop J, Veale M, Ayberk H, Szer J, Cooper I, Whiteside M (1988) Transient platelet and HLA antibody formation in multitransfused patients with malignancy. Br J Haematol 68:345-350
15. Moroff G, Garatty G, Heal JM, Mc Pherson BR, Stroncek D, Huang ST Ho W, Petzt LO, Leach MF, Lannon SS, Rowe JM, Salek MN, Arndt P, Foley K, Masel D, Postoway N (1992) Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 32:633-640
16. Murphy MF, Metcalfe P, Ord J, Lister TA, Waters AH (1987) Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. Br J Haematol 67:255-260
17. Novotny VMJ, van Doom R, Witvliet MD, Claas FHJ, Brand A (1995) Occurrence of allogenic HLA and non-HLA antibodies after transfusion prestorage filtered platelets and red blood cells: a prospective study. Blood 85:1736-1741
18. Popovskv MA (1996) Quality of blood components filtered before storage and at the bedside: implications for transfusion practice. Transfusion 36:470-474
19. Saarinen UM, Koskimies S, Myllylä G (1993) Systematic use of leukocyte-free blood components to prevent alloimmumzation and platelet refractoriness in multitransfused children with cancer. Vox Sang 65:286-292
20. Schiffer C (1991) Prevention of alloimmumzation against platelets. Blood 77:1-4
21. Sintnicolaas K, van Marwijk-Kooij M, van Prooijen HC, van Dijk BA, van Putten WLJ, Claas FHJ, Novotny VMJ, Brand A (1995) Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study. Blood 85:824-828
22. Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum cytotoxins. Nature 204:998
23. van Marwijk Kooy M, van Prooijen HC, Moes M, Bosma-Stants I, Akkerman JWN (1991) Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization. Blood 77:201-205